1. Home
  2. Analysis
  3. Arnuity-ellipta
  4. Topamax

Arnuity ellipta and Topamax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta (fluticasone furoate) and Topamax (topiramate). Common drug interactions include musculoskeletal discomfort among females.

The phase IV clinical study analyzes what interactions people have when they take Arnuity ellipta and Topamax. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 58,954 Topamax users. Check the latest studies of Topamax.

On Jul, 16, 2026

13 people who take Arnuity ellipta and Topamax together, and have interactions are studied.

Arnuity ellipta and Topamax drug interactions.

What are the common drug interactions of Arnuity Ellipta and Topamax, by gender? *:

female:

  1. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Disturbance in attention
  4. Fatigue (feeling of tiredness)
  5. Fibromyalgia (a long-term condition which causes pain all over the body)
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Nausea (feeling of having an urge to vomit)
  8. Neuropathy peripheral (surface nerve damage)
  9. Nonalcoholic fatty liver disease
  10. Pain in extremity

male:

n/a

What are the common drug interactions of Arnuity Ellipta and Topamax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Back pain
  2. Chest pain
  3. Drug ineffective
  4. Hypertension (high blood pressure)
  5. Pruritus (severe itching of the skin)
  6. Rash
  7. Urinary tract infection
  8. Weight increased

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 53.85%
  2. Asthma: 3 people, 23.08%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 15.38%
  5. Hypersensitivity: 1 person, 7.69%
  6. Back Pain: 1 person, 7.69%
  7. Bladder Disorder: 1 person, 7.69%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 7.69%
  9. Depression: 1 person, 7.69%
  10. Gastric Ulcer (stomach ulcer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Topamax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Arnuity ellipta and Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topamax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topamax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone furoate and topiramate (the active ingredients of Arnuity ellipta and Topamax, respectively), and Arnuity ellipta and Topamax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.